Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is to evaluate the long-term immunogenicity of a boost dose of MVA-BN vaccine
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Men aged over 18 years
• Have received two doses of MVA-BN vaccine as an initial schedule
• Eligible for a booster dose of MVA-BN (according to the HAS recommendation)
• Be eligible and wish to initiate PrEP-HIV treatment or be followed for PrEP-HIV treatment
• Covered by social security (excluding AME)
Locations
Other Locations
France
CIC 1417Cochin-Pasteur
RECRUITING
Paris
Contact Information
Primary
Liem Binh Luong Nguyen, Degree medical doctor
liem.luong@aphp.fr
0033 1 58 41 28 58
Backup
Odile LAUNAY, PUPH
odile.launay@aphp.fr
0033 1 58 41 28 58
Time Frame
Start Date: 2025-05-07
Estimated Completion Date: 2027-11
Participants
Target number of participants: 90
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris